We are live on
!
Find out more
EAM
Exane Asset Management Portfolio holdings
AUM
$277M
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
-1.3%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$258M
AUM Growth
+$65.7M
(+34%)
Cap. Flow
+$68M
Cap. Flow
% of AUM
26.4%
Top 10 Holdings %
Top 10 Hldgs %
62.2%
Holding
40
New
15
Increased
9
Reduced
8
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$20.1M |
| 2 |
Gilead Sciences
GILD
|
+$16.9M |
| 3 |
QGENF
QIAGEN NV
QGENF
|
+$14.3M |
| 4 |
PPG Industries
PPG
|
+$12.9M |
| 5 |
Air Products & Chemicals
APD
|
+$12.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$40.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$10.3M |
| 3 |
MON
Monsanto Co
MON
|
+$8.56M |
| 4 |
Westlake Corp
WLK
|
+$7.45M |
| 5 |
Sherwin-Williams
SHW
|
+$6.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.4% |
| 2 | Materials | 17.75% |
| 3 | Communication Services | 12.17% |
| 4 | Financials | 11.68% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRFS
26
Grifois
GRFS
$5.13B
| $1.94M | 0.75% |
+116,300
| New | +$1.83M |
|
|
HES
27
DELISTED
Hess
HES
| $1.65M | 0.64% |
27,401
-20,628
| -43% | -$1.19M |
|
28
SLB Ltd
SLB
$70.6B
| $783K | 0.3% |
9,900
-18,669
| -65% | -$1.43M |
|
29
Occidental Petroleum
OXY
$57.3B
| $672K | 0.26% |
8,888
-4,164
| -32% | -$311K |
|
|
WFT
30
DELISTED
Weatherford International plc
WFT
| $569K | 0.22% |
+102,550
| New | +$669K |
|
|
CLR
31
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $536K | 0.21% |
+11,830
| New | +$465K |
|
32
TechnipFMC
FTI
$30.3B
| $430K | 0.17% |
+21,692
| New | +$449K |
|
33
Biogen
BIIB
$29.6B
| – | – |
-73
| Closed | -$19K |
|
34
Regeneron Pharmaceuticals
REGN
$68.3B
| – | – |
-40
| Closed | -$14.4K |
|
|
35
Sherwin-Williams
SHW
$76.6B
| – | – |
-70,257
| Closed | -$6.67M |
|
36
Telefônica Brasil
VIV
$21.9B
| – | – |
-27,510
| Closed | -$344K |
|
|
37
Westlake Corp
WLK
$9.64B
| – | – |
-160,860
| Closed | -$7.45M |
|
|
MON
38
DELISTED
Monsanto Co
MON
| – | – |
-97,591
| Closed | -$8.56M |
|
|
JOY
39
DELISTED
Joy Global Inc
JOY
| – | – |
-70,500
| Closed | -$1.13M |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| – | – |
-103,368
| Closed | -$10.3M |
|
Similar funds
RCA
TAM
IIA
TAP
TLA
1NWS
RFA
EFP
Exane Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Exane Asset Management held 40 positions worth $258M, up 34% from $192M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Exane Asset Management deployed $68M of net new capital in Q2 2016, opening 15 new positions and adding to 9 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 141,454 shares worth $16.5M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 25% a quarter earlier, followed by Materials and Communication Services.
On the sell side, the largest reduction was T-Mobile US, an estimated $40.9M trimmed.
- Exane Asset Management's largest Q2 2016 buy was Alexion Pharmaceuticals: 141,454 shares worth $16.5M.
- Exane Asset Management added most to Gilead Sciences in Q2 2016, an estimated $16.9M increase.
- Exane Asset Management's biggest Q2 2016 reduction was T-Mobile US, cutting an estimated $40.9M.
- Exane Asset Management fully exited Celgene Corp in Q2 2016, selling an estimated $10.3M.
- Exane Asset Management's ten largest holdings make up 62% of its $258M portfolio in Q2 2016.
- Exane Asset Management opened 15 new positions and closed 8 in Q2 2016.
- Exane Asset Management's portfolio value rose 34% quarter-over-quarter to $258M.
Based on Exane Asset Management's 13F filing for Q2 2016, filed 4 Aug 2016.